PUBLICATIONS · 23724913
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2013 Jun 20
- First author
- Shaw AT
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2015 Oct 15;373(16):1582. doi: 10.1056/NEJMx150036.
- note
- Source null
- related pmid
- 26466010
- relationship
- Erratum in
Authors and identifiers
- name
- Shaw AT
- type
- Author
- name
- Kim DW
- type
- Author
- name
- Nakagawa K
- type
- Author
- name
- Seto T
- type
- Author
- name
- Crinó L
- type
- Author
- name
- Ahn MJ
- type
- Author
- name
- De Pas T
- type
- Author
- name
- Besse B
- type
- Author
- name
- Solomon BJ
- type
- Author
- name
- Blackhall F
- type
- Author
- name
- Wu YL
- type
- Author
- name
- Thomas M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shaw AT
- type
- Author
- name
- Kim DW
- type
- Author
- name
- Nakagawa K
- type
- Author
- name
- Seto T
- type
- Author
- name
- Crinó L
- type
- Author
- name
- Ahn MJ
- type
- Author
- name
- De Pas T
- type
- Author
- name
- Besse B
- type
- Author
- name
- Solomon BJ
- type
- Author
- name
- Blackhall F
- type
- Author
- name
- Wu YL
- type
- Author
- name
- Thomas M
- type
- Author
- bibliography ids
- nci-bib-8c9806b71a76d5a26a758691
- book metadata
- content sha256
- 0ecd4682d97963dc532f61166206feb81d98b7dc90a3f77e0df301e68a5c1918
- document type
- citation
- dois
- 10.1056/NEJMoa1214886
- electronic publication date
- display
- 2013 Jun 1
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23724913
- immutable id
- pubmed:23724913@0ecd4682d97963dc532f61166206feb81d98b7dc90a3f77e0df301e68a5c1918
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 25
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 2385-94
- volume
- 368
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2015 Oct 15;373(16):1582. doi: 10.1056/NEJMx150036.
- note
- Source null
- related pmid
- 26466010
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 23724913
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- 060c50bf59c1822635e7976b1b48d9e54cf132afb2e467741bb947c23ace7da5
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Jun 20
- precision
- day
- year
- 2013
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
Preserved source evidence · Not medical advice
Triangle